This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (54) Citing Articles via Google Scholar Google Scholar Articles by Williams, E. S. Search for Related Content PubMed PubMed Citation Articles by Williams, E. S. Social Bookmarking                            What's this?

Chronic Wasting Disease

Department of Veterinary Sciences, University of Wyoming, Laramie, WY

	Abstract

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
Chronic wasting disease (CWD) is a unique transmissible spongiform encephalopathy (TSE) of mule deer (Odocoileus hemionus), white-tailed deer (O. virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni). The natural history of CWD is incompletely understood, but it differs from scrapie and bovine spongiform encephalopathy (BSE) by virtue of its occurrence in nondomestic and free-ranging species. CWD has many features in common with scrapie, including early widespread distribution of disease-associated prion protein (PrP^d) in lymphoid tissues, with later involvement of central nervous system (CNS) and peripheral tissues. This distribution likely contributes to apparent efficiency of horizontal transmission and, in this, is similar to scrapie and differs from BSE. Clinical features and lesions of CWD are qualitatively similar to the other animal TSEs. Microscopically, marked spongiform lesions occur in the central nervous system (CNS) after a prolonged incubation period and variable course of clinical disease. During incubation, PrP^d can be identified in tissues by antibody-based detection systems. Although CWD can be transmitted by intracerebral inoculation to cattle, sheep, and goats, ongoing studies have not demonstrated that domestic livestock are susceptible via oral exposure, the presumed natural route of exposure to TSEs. Surveillance efforts for CWD in captive and free-ranging cervids will continue in concert with similar activities for scrapie and BSE. Eradication of CWD in farmed cervids is the goal of state, federal, and industry programs, but eradication of CWD from free-ranging populations of cervids is unlikely with currently available management techniques.

Key words: Chronic wasting disease; elk; mule deer; prion disease; transmissible spongiform encephalopathy; white-tailed deer.

The transmissible spongiform encephalopathies (TSEs) are unusual infectious diseases of animals and humans. The TSEs, including chronic wasting disease (CWD), are designated prion diseases because of their association with aberrantly refolded isoforms of the prion protein, a normal cellular glycoprotein (PrP^C).¹²⁰ CWD-associated prion protein (PrP^CWD or PrP^d)⁸² is widespread in the lymphoid tissues and the CNS from early in the incubation phase until death.^98,132,137 Scrapie, the first TSE identified, was the focus of considerable research and even controversy concerning its origin and nature (genetic versus infectious) for many years.^2,114,115 However, it was the recognition that prion diseases were transmissible and affected humans as well as animals that stimulated much of the current scientific interest in the nature of these diseases.

Scrapie has been recognized for hundreds of years, transmissible mink encephalopathy (TME) for more than 50 years, CWD for more than 30 years, and bovine spongiform encephalopathy (BSE) for fewer than 20 years. Although CWD is now well known, it was just a few years ago considered an obscure disease of mule deer (Odocoileus hemionus) and elk (Cervus elaphus nelsoni) in a limited area of North America. The first published reports of CWD were in the early 1980s,^157,158 but well before that time, biologists working in facilities in which this disease occurred recognized CWD as a syndrome that limited the lifespan of the captive mule deer they were studying. It was years before it was determined that this wasting syndrome of deer was contagious. Since the BSE epidemic, followed by recognition of the associated variant Creutz-feldt-Jacob disease (vCJD) of people, there has been much greater scientific and public attention paid to TSEs in general and concordant increased interest in understanding CWD. This has resulted in studies of CWD that now span the spectrum from pathogenesis to spatial epidemiology.

CWD occurs among two very different populations of cervids: deer and elk that are raised and managed in much the same way as other ruminants in agricultural systems and free-ranging deer and elk populations that are under much less human control. Understanding differences in epidemiology and management strategies that can be employed to control or eradicate CWD for these two populations of animals is critical. In this review, I will survey the rapidly accumulating knowledge about CWD with a focus on information most relevant for veterinary pathologists.

	Clinical and Epidemiologic Features

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
Descriptions of clinical CWD are based primarily on observations of captive animals; the progression of CWD in free-ranging animals is less well known because of the inherent difficulties in their study. Features of CWD in terminal clinical stages are readily appreciated, even by untrained observers and have been described.^155,159 Qualitatively, they are similar to sheep with terminal scrapie⁴⁰ or cattle with BSE,¹⁵¹ although disruptions and alterations of locomotion can be more subtle in CWD. The salient clinical features of progressive CWD disease in adults is weight loss and behavioral changes that typically span weeks or months. In addition to these general nonspecific features, signs that might only be present in some cases include odontoprisis; sialorrhea, or excess salivation because of difficulty swallowing; ataxia and head tremors; esophageal dilation and regurgitation; and aspiration pneumonia. Terminal physiologic and behavioral alterations can include polydipsia and polyuria; syncope; periods of lack of awareness; fixed stare; changes in interaction with herdmates and handlers (decreased or increased flight distances); altered stance, often with lowered head; repetitive walking of perimeters of enclosures; and hyperexcitability when handled. In general, the signs of terminal CWD are more subtle in elk than in deer. Elk more often have disturbances in locomotion and less often display polydipsia than deer.

Pruritus with hair loss, commonly observed in terminal sheep scrapie, is not a feature of advanced CWD. However, the hair coat of affected animals can be rough and dry,¹⁵⁸ with patchy retention of the winter hair coat in summer.^10,159 This appears to be a reflection of poor body condition rather than a primary effect of the disease.

No specific clinical diagnostic feature of CWD appears during the early to midphase of disease. Behavioral changes can be subtle and fall within the normal repertoire of cervids. Similarly, normal seasonal changes in body mass occur in free-ranging and captive cervids; thus, evaluation of body condition must take into account time of year, nutritional or habitat quality, and reproductive status.

Polydipsia and consequent polyuria in terminal cases of CWD are probably associated with damage to the supraoptic and paraventricular nuclei and diabetes insipidus.¹⁵⁷ With the exception of low urine specific gravity, found in terminally affected cervids with free access to water,^157,158 clinical chemistry and hematology are not useful in diagnosis of CWD. Alterations from normal cervid values reflect nonspecific changes from poor body condition, aspiration pneumonia, or another intercurrent disease process. Specific physiologic studies have not been conducted on CWD-affected cervids.

Deer with subclinical or early clinical CWD are susceptible to sudden death after handling¹⁰⁰ and are more likely to die following immobilization or misadventure than unaffected deer¹⁵⁵ (L. Wolfe et al., personal communication; W. Cook et al., personal communication). Although the mechanism of this posthandling mortality has not been identified, functional lesions in the parasympathetic innervation of the heart have been identified in BSE;⁷ similar processes might occur in CWD, accounting for acute mortality following significant stress.

Aspiration pneumonia can occur early or late in the clinical course of CWD^155,159 and could be responsible for apparent rapid death, even in the absence of other signs of CWD. Thus, CWD should be considered in any adult cervid with aspiration pneumonia.¹⁵⁶ Aspiration pneumonia presumably follows loss of effective motor control over swallowing associated with regurgitation or rumination due to central damage.¹⁵⁹

Subclinical or clinically apparent changes in behavior could increase the likelihood of an affected free-ranging deer or elk being harvested during the fall hunt,³⁵ succumbing to collisions with vehicles,^90,100 or being killed by predators⁹⁰ (M. Miller, personal communication).

Duration of clinical disease is extremely variable and in part might reflect difficulty in determining the onset of clinically apparent CWD. Astuteness in detection of subtle clinical signs might require considerable familiarity with the individual animal; this is not possible in many captive herds and is essentially impossible in free-ranging cervids. Sudden death might occur rarely in captive deer,¹⁰⁰ and short duration of disease (days) is occasionally observed in elk (W. Schultz and T. Kreeger, personal communication). More often, a slowly progressive clinical course of "ain't doing right" is noted over weeks or months. Death typically occurs within 4 months, although a few animals survive as long as a year.¹⁵⁵ Death of clinically affected animals might follow environmental stresses, such as periods of extreme cold. Because of a compromised ability to forage, find water, and possibly avoid predators, clinical duration is likely to be shorter in free-ranging cervids compared with cervids maintained in captivity.

Because of prolonged incubation periods, which in the natural disease is a minimum of approximately 16 months, fawns do not develop clinical CWD, although evidence of infection can be detected by a variety of methods through much of the incubation period.^111,132 Under experimental conditions, disease-associated prion protein (PrP^d) was found in lymphoid tissues of the alimentary tract in mule deer by 42 days postoral exposure.¹³² Only rarely are yearlings clinically affected. Maximum incubation periods of naturally exposed free-ranging animals are difficult to determine because it is impossible to determine exactly when an animal is exposed, but average incubation periods probably range from 2 to 4 years. However, CWD has been diagnosed in an elk >15 years of age^155, a mule deer >12 years of age (unpublished data), and in white-tailed deer of >5 years of age¹¹¹ residing in CWD endemic facilities with high prevalence of the disease. These cases might represent animals exposed to the CWD agent as adults or could indicate prolonged incubation periods. The influence of dose of agent on duration of incubation is not clear in CWD, but preliminary observations of experimentally and naturally exposed captive elk suggest that, to a degree, higher doses result in shortened incubation periods (E. S. Williams, unpublished data; T. Kreeger, personal communication). Incubation periods in rodents exposed to scrapie^48,88,121 are inversely related to dose of TSE agent, and a similar trend appears to be present in cattle orally exposed to BSE agent (G. Wells, personal communication).

Seasonality is not a significant feature of CWD at the individual level because animals can develop clinical CWD at any time of the year. However, on a population level, affected animals are more commonly reported in the fall, perhaps because of an observational bias, or in the winter, possibly reflecting increased environmental stress.

Epidemiologic features should be considered when investigating possible cases of CWD. In farmed herds naturally affected by CWD, rarely will more than one animal be affected at a time,^87,117,134 although there is often herd history of ill thrift in adult animals. Deer and elk from captive herds that have a history of frequent purchases from unmonitored sources or from herds in known CWD endemic areas (Fig. 1) are at greater risk for CWD than animals from closed and monitored herds and from herds outside CWD endemic areas.

View larger version (35K): [in this window] [in a new window]   Fig. 1. Known historic distribution of chronic wasting disease in farmed and free-ranging cervids in North America, 1977–2004. Dark gray jurisdictions indicate where CWD has been identified in farmed cervids; to date all but a few identified farmed cervid herds known to have had CWD have been depopulated. Red foci are areas where CWD has been diagnosed in free-ranging cervids. The yellow focus indicates occurrence of CWD in mule deer in a zoological garden. In March–May 2005, the New York State Department of Agriculture and Markets announced five positive cases of chronic wasting disease in captive white-tailed deer from two closely connected herds in central New York (Oneida County) and two positive cases in wild white-tailed deer from the same area.104.

Prevalence of clinical or subclinical CWD infection as detected by immunohistochemistry (IHC) of lymphoid tissue or brain in captive herds varies considerably from <1% in some farmed herds with recent introduction of the disease to essentially 100% in CWD endemic research facilities.^111,117,157 Likewise, prevalence varies widely in free-ranging populations from <1% in deer and elk to 30% in some local populations of deer¹⁰³ (W. Cook, personal communication; Wyoming Game and Fish Department and Colorado Division of Wildlife, unpublished data). Prevalence of CWD in elk is lower than in sympatric deer.¹⁰¹

	Gross Pathology

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
As in the other animal TSEs, individual gross lesions of CWD are nonspecific, but in combination, they may be helpful in diagnosis of CWD. Lesions that might be present reflect the clinical signs: rough, dry hair coat that might not have been appropriately shed and megaesophagus. It is important to realize that body condition of animals in subclinical or early clinical stages of CWD can be normal; good body condition does not rule out CWD. In the terminal stages of disease, typically the animals are emaciated; might or might not have aspiration pneumonia; often have watery rumen contents, which can be frothy or contain increased amounts of sand and gravel; and have dilute urine if water was freely available.^155,159 Carcasses of free-ranging deer and elk might be dehydrated, presumably due to a lack of ready access to water. Other potential causes of emaciation and pneumonia should be ruled out during the course of postmortem examination of cervids suspected of having CWD.

	Histopathology and Electron Microscopy

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
The histopathology of CWD in clinically affected animals is typical of the ruminant TSEs;^{53,138,153,160} specific histologic lesions are only observed in gray matter of the CNS. Qualitatively, lesions observed in brains of natural and experimental (intracerebral or oral routes of exposure) cases of CWD in natural hosts are the same; duration of clinical disease does not significantly affect lesion distribution or severity,¹⁶⁰ and lesions of CWD in free-ranging and captive mule deer are similar.¹³⁷ Some variation in severity can occur among individuals but the anatomic distribution of lesions is quite constant. CNS lesions are bilaterally symmetrical and spongiform change is obvious; vacuolization occurs in neuronal perikarya and neuronal processes. Neuronal degeneration and astrocytic hyperplasia and hypertrophy occur^53,160 but are not prominent features. As with the other TSEs, inflammatory cell response is not apparent unless associated with intercurrent disease.

Microscopic lesions are most striking in the dien-cephalon, olfactory cortex, and nuclei of the medulla oblongata, prominently the dorsal vagal nucleus, although milder lesions are widespread in brain and spinal cord, with relative sparing of the basal ganglia, cerebral cortex, and hippocampus.^137,160 In clinically affected cervids, examination of well-fixed medulla oblongata at the level of the obex is considered sufficient for diagnosis of CWD,¹⁶⁰ and sections at this level were used for CWD surveillance before availability of immunohistochemistry.

Amyloid plaques are relatively common and can be detected on hematoxylin and eosin (HE)–stained brain sections, most prominently and with decreasing frequency, in white-tailed deer, mule deer, and elk (E. S. Williams, unpublished data). These appear as slightly pale fibrillar eosinophilic areas of neuropil in HE preparations (Fig. 2a) and can be surrounded by vacuoles ("florid plaques").^94,153,160 These are more easily detected with silver stains,¹⁶⁰ with Congo red staining,⁸ or, most dramatically, by immunohistochemistry^51,52,94,95 for detection of PrP^d (Fig. 2b). Amyloid plaques have been reported in a variety of other TSEs, including kuru,⁵⁶ sporadic CJD,¹³ murine scrapie,²⁹ BSE in macaques (Macaca fascicularis),⁹³ and rarely in BSE and scrapie,^14,53,82,165 and they are a salient lesion of vCJD in humans.¹⁵² Thus, the presence of amyloid plaques is not reflective of a particular strain of agent, but rather, it presumably reflects the interplay between host and pathogen.

View larger version (91K): [in this window] [in a new window]   Fig. 2. Thalamus; white-tailed deer with chronic wasting disease. Amyloid plaques. Fig. 2a. Formalin-fixed, paraffin-embedded tissue, HE. Amyloid plaques delineated with arrows. Bar x 10 µm. Fig. 2b. Immunohistochemical stain of amyloid plaques. Bar x 10 µm.

Usefulness of IHC in diagnosis of TSEs, for study of natural and experimental pathogenesis of these diseases and for strain typing, is well established^{51,65,82,97,146,149} and offers a sensitive method for detection of PrP^d while maintaining structural context. Obtaining brains from free-ranging and extrinsically managed captive cervids free of significant autolytic change can be difficult which often precludes use of histopathology alone for diagnosis of CWD. In addition, histopathology is only sensitive for diagnosis of clinically affected cervids; it is insensitive in subclinical CWD⁹⁸ because spongiform encephalopathy occurs at about the same time clinical signs develop (E. S. Williams, unpublished data).

Patterns of PrP^d deposition in CWD-affected cervid brains include perineuronal accumulation, extracellular plaques and granular deposits, perivascular accumulation, and subependymal and subpial deposition.^52,94,137 In clinical CWD, widespread staining of PrP^d occurs throughout the brain in susceptible species (Table 1). ^136,138,153 Typically, correlation is good between deposits of PrP^d and regions of spongiform change (Fig. 3a, b);¹³⁶ however, PrP^d can be found in areas of the brain with no spongiform change. Spraker et al.¹³⁷ exhaustively documented deposition of PrP^d in mule deer brain in various stages of CWD infection.

View larger version (170K): [in this window] [in a new window]   Fig. 3. Tonsil; mule deer with chronic wasting disease. Formalin-fixed, paraffin-embedded tissue. Immunohistochemical stain demonstrating accumulation of disease associated prion protein in germinal centers. Bar = 100 µm.

Specific granular PrP^d labeling can be present in the light and dark zones of germinal centers (Fig. 4), but staining is less often identified in the follicular mantle. In studies of tonsils of mule deer early and late in incubation by triple label immunofluorescence and confocal microscopy, PrP^d was detected primarily in extracellular locations in association with follicular dendritic and B-cell membranes.¹³⁰ Aggregates of PrP^d also were found in tingible body macrophages within follicular germinal centers.

View larger version (95K): [in this window] [in a new window]   Fig. 4. Dorsal vagal nucleus and hypoglossal nucleus in obex region of the medulla oblongata; mule deer with chronic wasting disease. Fig. 4a. Formalin-fixed, paraffin-embedded tissue, HE. Spongiform encephalopathy in the dorsal vagal nucleus (upper half of photomicrograph) and unaffected hypoglossal nucleus (lower half of photomicrograph). Bar = 50 µm. Fig. 4b. Immunohistochemical stain. Marked staining of the dorsal vagal nucleus with a sharp line of demarcation with the unaffected hypoglossal nucleus. Bar = 50 µm.

Recent studies in laboratory rodent models of scrapie demonstrated PrP^d in skeletal muscles^{22,103,141,142,} and two studies found infectivity for rodents in muscle.^22,142 PrP^d has also been demonstrated in skeletal muscles of humans with CJD⁴⁵ and of sheep with scrapie,⁶ suggesting skeletal muscles as a source of infectivity for TSEs. No evidence of PrP^d was found in sections of skeletal muscle from deer with natural¹³⁸ and experimental⁶⁰ CWD by IHC, but additional studies are warranted and are underway.

Classification systems for the stages of CWD infection in naturally affected mule deer and elk based on histologic lesions and deposition of PrP^d have been proposed^{98,134, 137}. The essence of these systems is that, during the course of incubation, PrP^d is typically detected first in lymphoid tissues followed by deposition in the lateral aspect of the dorsal vagal nucleus in the medulla oblongata in the absence of spongiform change. Spongiform change then occurs in the vagal nucleus, probably at about the onset of clinical disease, followed by more widespread deposition of PrP^d and spongiform change in the brain. Variations in this pattern occur in individual animals. The usefulness for management purposes of such stage description systems has yet to be shown, but they have been used in attempting to evaluate the influence of genetics on pathogenesis.¹¹¹

	Diagnostic Techniques

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
The search for simple and reliable antemortem tests for TSE agents continues. Biopsy of the lymphoid tissue of the third eyelid^105,107,109 or the tonsil^129,146 and examination of the tissue by IHC for PrP^d have proven useful in diagnosis of scrapie in live sheep. Tonsil biopsy of live mule deer and white-tailed deer for CWD testing has been useful in a research context^112,150,163 (W. Cook, D. Edmonds, and E. S. Williams, unpublished data; N. Mathews, personal communication) and, more recently, in evaluation of management strategies (test and removal) for a local population of free-ranging mule deer in Colorado.¹⁶⁴ Tonsil biopsy is not practical on a large scale because it requires anesthesia of the animal before sampling. Sampling lymphoid tissue from the nictitating membrane of deer and elk has not proven to be as useful as in sheep (K. O'Rourke, personal communication; L. Wolfe, personal communication).

Immunohistochemistry is considered the "gold standard" for diagnosis of CWD.^112,145 Protocols for IHC employ various techniques for antigen retrieval and a variety of antibodies (Table 2) and chromagens.^106,130,136 For regulatory purposes, standard IHC protocols are used in US Department of Agriculture–approved laboratories and include hydrated autoclaving, formic acid treatment of sections, specified antibody, and automated staining of retropharyngeal lymph node samples from deer and retropharyngeal lymph node or obex samples, or both, from elk and deer. Retropharyngeal lymph nodes are used in deer because of early lymphoid deposition of PrP^d at this location, making testing more sensitive than if brain alone was used.^71,98 For maximum sensitivity, multiple sections of lymph node should be examined because of patchy PrP^d deposition in early infection.⁷¹ Retropharyngeal lymph node is positive in the majority of elk with CWD infection; however, 10–15% of elk have detectable PrP^d in brain but not retropharyngeal lymph node¹³⁴ (E. S. Williams, J. Kreeger, and H. Edwards, unpublished data), leading to recommendations to test both lymph node and obex samples in elk. Rapid screening tests for the TSEs, including CWD, are in increasingly wide usage. Five rapid tests have been licensed by the US Department of Agriculture, Center for Veterinary Biologics, for CWD testing (enzyme-linked immunosorbent assays [ELISAs]: Bio-Rad Chronic Wasting Disease Test, BioRad Laboratories, Hercules, CA; HerdCheck CWD Antigen EIA Test, IDEXX Laboratories, Westbrook, ME; Enfer TSE Test, Abbott Laboratories, Abbott Park, IL; and CWD Dot Blot ELISA Test, VMRD Inc., Pullman, WA; and a strip test: PDL CWD Rapid Antigen Test, Prion Development Laboratory, Buffalo Grove, IL). Sensitivity of IHC compared with these rapid detection methods depends on the techniques and tissues used, and there are few controlled direct comparisons. In a large study of hunter-harvested cervids in Colorado and with IHC results as the gold standard, one ELISA (Bio-Rad) was 98.3% and 100% sensitive on retropharyngeal lymph nodes from mule deer and elk, respectively.⁷¹ Specificity was essentially 100% for both species.

	Differential Diagnoses

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

In much of North America, hemorrhagic disease (epizootic hemorrhagic disease and bluetongue) can cause clinical signs compatible with CWD. Occasionally, encephalitis can occur in white-tailed deer and elk with acute hemorrhagic disease, leading to clinical neurologic manifestations that could slightly resemble signs of CWD. Chronic hemorrhagic disease can result in emaciation of white-tailed deer and, rarely, mule deer, and affected animals are occasionally observed in late fall or winter. The lesions and epidemiology of epizootic hemorrhagic disease and bluetongue in cer-vids have been reviewed⁷⁴; histopathology, IHC, virus isolation, and serology can be used to distinguish these diseases.

In eastern North America, meningeal worm (Parelaphostrongylus tenuis) infection is relatively common in populations of white-tailed deer, the reservoir host; although uncommon, CNS disease occasionally occurs in this species. Mule deer and elk can be seriously affected. The nematodes migrate through spinal cord and brain, resulting in local traumatic and inflammatory damage. The lesions and epidemiology of disease caused by this parasite have been reviewed.⁹¹ Meningeal worm only occurs in a few areas in which free-ranging populations of elk and mule deer exist, but farmed elk and mule deer are at risk of infection in areas in which this parasite is present.

Loss of condition and behavioral changes occur in elk with locoweed intoxication,¹⁶² and these signs can resemble CWD. The microscopic lesions of locoism in the CNS¹ are easily differentiated from CWD. Naturally occurring locoism has not been described in deer.

	Pathogenesis

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
Studies of the pathogenesis of scrapie in natural hosts and in laboratory rodents have proven to be good models for investigating CWD. Before the availability of immunoassays for tracking the presence of PrP^d, bioassay of tissues for scrapie agent was by intracerebral inoculation of mice,^55,89 an expensive and time-consuming method. More recently, elegant studies on scrapie agent by IHC have tracked accumulation of PrP^d throughout the body during incubation.^{4,15–17,67–70,146–149} Scrapie agent in naturally and orally exposed animals enters via the alimentary tract; accumulation of PrP^d occurs in gut-associated lymphoid tissue—in particular, in germinal centers innervated by sympathetic fibers and in myenteric and submucosal plexuses—and moves to the CNS via sympathetic and parasympathetic nerves to the intermediolateral columns of the spinal cord and the parasympathetic vagal nucleus (dorsal nucleus of the vagus nerve) in the obex region of the medulla oblongata. From there, PrP^d can be found in increasing amounts and widening distribution in lymphoid tissues and CNS. A similar pattern appears to occur in deer with CWD, with involvement first of tonsil and gut-associated lymphoid tissues, presence of PrP^d in the enteric nervous system, followed by initial involvement of the CNS at the vagal nucleus and thoracic spinal cord and concurrent distribution in peripheral lymphoid tissues^{98,131,132,137} (Williams et al., unpublished data). More detailed studies of CWD pathogenesis in all three naturally susceptible species are underway.

Recent studies have detected prion infectivity in blood of sheep with scrapie and BSE^73,75 and has been suspected in humans with vCJD.^96,116 Occurrence of the agent in blood might account for the widespread distribution of PrP^d that occurs in lymphoid tissues in scrapie and possibly in CWD.

	Genetics

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
The influence of genetics on scrapie susceptibility, resistance, and incubation period has been recognized, investigated, and debated for decades.^{2,14,76–80,110,114,115} At least 10 amino acid polymorphisms in the protein encoding region of the sheep PrP gene have been reported,²³ and alleles at codons 136 and 171 strongly influence susceptibility and resistance. Now determination of PrP genotype and selection for resistant genotypes form an important aspect of programs to control this disease in North America (http://www.aphis.usda.gov/vs/nahps/scrapie/) and in some countries in Europe (http://www.defra.gov.uk/animalh/bse/othertses/scrapie/nsp/index.htmlh).³⁹

Investigations of possible genetic influences on CWD susceptibility are less extensive but ongoing (Table 3). The first such studies reported nucleotide sequences of the PrP gene and deduced amino acid sequences and compared them to those of domestic livestock or humans.^33,66,128 O'Rourke et al.¹⁰⁸ determined that elk with methionine homozygosity at codon 132 (132MM) were overrepresented among elk with CWD compared with elk heterozygous for methionine and the minor allele, leucine (132ML) or homozygous for leucine (132LL) at that locus. Although naturally acquired CWD has been diagnosed in elk with these three genotypes¹³² (J. Jewell, personal communication), evidence indicates that incubation period might be lengthened in elk with 132ML or 132LL genotypes (T. Kreeger et al., personal communication; E. S. Williams, unpublished data). If these observations are confirmed and expanded, some degree of genetic manipulation of farmed elk herds might be useful in management of CWD.

Three substitution polymorphisms occur in white-tailed deer PrP (Table 3) and two in mule deer, of which one (codon 20) is removed during processing and one (codon 225) remains in the mature polypeptide. The existence of a processed pseudogene of high sequence identity to the functional PrP gene in all mule deer and both black-tailed deer subspecies (O. hemionus columbianus and O. hemionus sitkensis)^24,85 (J. Jewell, personal communication) and about 25% of white-tailed deer¹¹¹ (J. Jewell, personal communication) complicated initial sequence studies of the deer prion protein. Thus, some deduced amino acid sequences reported before recognition of the pseudogene list a polymorphism at codon 138 (serine/asparagine); only serine is encoded at that locus by the functional deer PrP gene. In one population of white-tailed deer with high prevalence of CWD, presence of the pseudogene did not appear to influence presence or absence of disease.¹¹¹ Pseudogenes are rarely expressed, but functional pseudogenes have been described,⁹ warranting more investigation into the role that pseudogenes might play in CWD.

Results to date indicate that deer of all common PrP genotypes are susceptible to CWD. CWD was diagnosed in all major genotypes of white-tailed deer studied in Wisconsin and Nebraska;^86,111 however, fewer deer homozygous for serine at codon 96 were found with CWD than statistically expected. Captive mule deer heterozygous for serine/phenylalanine at codon 225 (225SF) are susceptible to experimental oral exposure but have prolonged CWD incubation periods compared with homozygous (225SS) deer.⁸⁴ A study of free-ranging mule deer in the CWD endemic areas of Wyoming and Colorado found that the 225SF genotype is less frequent among CWD-positive animals than in the overall population⁸⁴; thus, 296 positive animals included one SF and 295 SS genotypes, whereas 22 SF samples were expected statistically. In one Colorado mule deer herd sampled extensively, about 18% were 225SF. However, only 4% of the CWD-infected mule deer from the population that included this herd were of the SF genotype (J. Jewell, personal communication; M. Miller, personal communication).

Thus, in all three natural cervid hosts, the influence of genetics on CWD incubation periods and pathogenesis requires further understanding. Although no cer-vid genotype may provide complete resistance to CWD, if incubation periods and pathogenesis of CWD are significantly affected by genotype, as occurs in sheep scrapie, this might influence CWD epidemiology and have implications for development of management strategies for this disease.

	Host Range

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
The natural and experimental host ranges of CWD are shown in Table 4. Only three species—mule deer, white-tailed deer, and elk—are known to be naturally susceptible to CWD. Black-tailed deer (O. hemionus columbianus), a subspecies of mule deer, are susceptible to CWD.¹⁵⁷ It is likely, because of close taxonomic relationships, that all subspecies of white-tailed deer, mule deer, and elk (which includes red deer, C. elaphus elaphus) would be susceptible to CWD if appropriately exposed.

Domestic sheep are susceptible to CWD agent by intracerebral inoculation; Suffolk sheep of a genotype highly susceptible to scrapie (homozygous for glutamine [Q] at codon 171 [171QQ]) developed a disease indistinguishable from scrapie following inoculation (A. Hamir, personal communication). Susceptibility of domestic sheep to CWD agent by oral exposure has not been studied. One domestic goat developed CWD approximately 6 years after intracerebral inoculation of deer CWD brain.¹⁵⁹ Clinical signs included intense pruritis and loss of body condition. Microscopically, widespread spongiform encephalopathy resembled that of scrapie.

Currently, no widely available laboratory animal model exists for the study of CWD. Mink and ferrets are susceptible to CWD by intracerebral inoculation but have only been used in a limited number of CWD studies^11,92 (R. Marsh, personal communication; C. Sigurdson et al., personal communication; E. S. Williams, unpublished data). Conventional wild-type laboratory mice and hamsters are poor hosts for CWD agent; it transmits with low efficiency on first passage in mice²⁷ and only to hamsters following passage in domestic ferrets.¹¹ Lack of a suitable laboratory model for CWD has hampered study of some aspects of CWD biology. However, transgenic mice expressing normal cervid cellular prion protein (PrP^c) are being developed and validated by several laboratories²⁶ (M. Oldstone, personal communication; R. Rubenstein, personal communication) and availability of these animals in the future will be very useful in the study of CWD.

Based on epidemiologic investigations, there is currently no evidence that humans are susceptible to CWD,^18–20,167 although it is impossible to prove that humans are not susceptible to this agent.²¹ A few squirrel monkeys (Sciurus saimiri) were susceptible to CWD by intracerebral inoculation (R. Marsh and S. Young, personal communication), and expanded studies of nonhuman primate susceptibility to CWD are underway (R. Race, personal communication).

Deer and elk in CWD endemic areas are hunted for venison and consumed by local as well as nonresident families. Because it is not possible to provide absolute assurance that venison is without risk, hunting orders and Web sites in states and provinces with CWD in cervid populations provide information and guidance for the public about CWD (e.g., http://www.dnr.state.wi.us/org/land/wildlife/whealth/issues/CWD/, http://wildlife.state.co.us/CWD). Hunters are advised to avoid harvesting deer and elk that appear ill, to debone meat during processing, to wear latex or rubber gloves when dressing the carcass, and to avoid contact with brain, spinal cord, and lymphoid tissues. Regulations concerning requirements for harvested deer and elk to be tested for CWD vary among jurisdictions; in most locations, this is voluntary and available through state laboratories. Recommendations are that animals testing positive for any prion disease should not be consumed by humans or other animals.¹⁶⁷

	Origin and Strain Typing

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
The origin of CWD is not known and might never be known. Three hypotheses have been suggested. Perhaps the most plausible is that CWD derives from scrapie. Support for this hypothesis comes from the moderate ability of PrP^d from CWD-affected deer and elk to convert PrP^c from sheep to the abnormal isoform PrP^d125 and from comparisons of glycoform patterns on western blots of PrP^d from CWD-affected deer and elk and sheep scrapie.¹²³ In addition, scrapie agent inoculated intracerebrally causes a disease in elk similar to scrapie.^61,62 However, CWD is unlike any characterized scrapie strain in rodent models;^27,31 it does not appear to be transmissible to raccoons (Procyon lotor) as is scrapie,⁶³ and incubation period in an intracerebrally inoculated goat¹⁵⁹ was longer (6 years) than expected for scrapie. Alternatively, CWD might be a disease of mule deer after spontaneous alteration of PrP^c resulting in formation of an infectious prion protein. Although spontaneous generation of prions might be theoretically possible and has been suggested as the origin of some cases of sporadic CJD of humans,^44,119,120 it would be exceedingly difficult if not impossible to prove retrospectively. A third possibility is that CWD is derived from another, currently un-identified, source of infection. Although it seems highly unlikely, a human source of CWD can not be completely dismissed; Hadlow⁵⁴ reminds us that, at least experimentally, TSE agents are transmissible from humans to animals.

The epidemiology of CWD is most compatible with a single strain that originated in mule deer and then infected elk and white-tailed deer.¹⁵⁹ CWD was first recognized as a clinical syndrome in mule deer many years before it was detected in elk housed in facilities with CWD-affected mule deer.¹⁵⁹ The first recognition of CWD in white-tailed deer was in free-ranging deer sympatric with CWD-affected mule deer and elk by retrospective examination of tissues when IHC for PrP^d became available.¹⁵⁵

Characteristics of histologic lesions have been used for decades to distinguish forms of human and natural and experimental animal TSEs.^31,42,113 Typing TSE strains in rodents is based on intracerebral inoculation of genetically characterized mice with the agent of interest and then comparing lesion profiles on the basis of vacuolation scores in specified areas of the brain of affected mice and incubation periods.⁴² Multiple strains of scrapie have been characterized in mice.^28,30,43 One mule deer source of CWD (captive mule deer from Colorado) was tested in this system, and it was found to be unlike any scrapie strains, BSE, TME, vCJD, or strains of sporadic CJD.^27,31 The mule deer CWD source examined differed from other TSE sources studied in mice, giving a unique lesion profile and presence of marked perivascular amyloid deposits.²⁷ Microscopic characterization of BSE and scrapie strains in sheep has been evaluated recently with patterns of PrP^d deposition by IHC^46,83 and a panel of antibodies recognizing different PrP epitopes, providing yet another way of potentially evaluating strains of the TSE agents.

Another proposed system for distinguishing animal TSE strains uses intracerebral inoculation of raccoons.^57,64 Incubation time of TME in raccoons was very short (5–6 months), incubation time of scrapie was moderate (about 2 years), and at the time the study was published, raccoons had not developed evidence of CWD infection. However, many more sources of TSE agents would need to be tested in raccoons before this could be considered a useful system for strain typing.

Recently, comparison of the relative amounts of di-, mono-, or unglycosylated PrP^d detected by immunoblotting, or glycoform pattern analysis, is receiving considerable attention as a method of determining strains of TSE agents and as a potential epidemiologic tool, although a plea for caution in the use of this technique alone was recently published.¹¹⁸ Multiple forms of PrP^d appear to be produced by different cell types after infection with the same TSE agent, suggesting that structural differences in PrP^d do not invariably code for different strains of scrapie;⁸² this could also be the case for CWD. The diglycosylated forms of PrP^d predominate in cervids with CWD¹²³ (Fig. 5).

View larger version (65K): [in this window] [in a new window]   Fig. 5. Western immunoblot of chronic wasting disease–associated prion protein; brain from mule deer (left) and white-tailed deer (right). The strongest signal is in the upper diglycosylated band and the weakest in the lower unglyco-sylated band.

Other molecular techniques for investigation of TSE strains have been applied to CWD. In vitro analysis of the ability of cervid PrP^d to convert PrP^c of various species to the abnormal isoform indicated a greater degree of conversion of ovine PrP^c to PrP^d than either bovine or human PrP^c but less than conversion of homologous PrP^c.¹²⁵ Conformation-dependent immunoassay, an assay that recognizes PrP^d without the need for proteinase treatment, has also been applied to PrP^d from a small number of CWD-affected cervids.¹²⁷ In these analyses, PrP^d from elk could be distinguished from that of mule and white-tailed deer, suggesting possible strain differences; the explanation for these differences has not been determined. Links between scrapie and CWD have been proposed on the basis of similarity of ribosomal DNA sequences from Spiroplasma mirum in sheep with scrapie and elk with CWD;¹² however, the evidence provided was weak and association of S. mirum with the TSEs is not widely accepted.

	Transmission

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
Although the exact method of transmission of CWD is not known, horizontal and indirect transmission appear to be the most important routes of spread.⁹⁹ Epidemiologic observations suggest that in addition to transmission within species, CWD can be transmitted from elk to mule deer and white-tailed deer, from mule deer to elk, and from mule deer to white-tailed deer.¹⁵⁶ Maternal transmission, if it occurs, does not appear to play a significant role in the epidemiology of the disease.⁹⁹ To date, PrP^d and infectivity have not been identified in placentas of deer and elk. This is in contrast to scrapie, in which high levels of infectivity reside in the placenta,^{5,122,143,144} and epidemiologic investigations have found that transmission at the time of lambing appears to be important in maintaining scrapie in flocks.

Results of a series of studies investigating CWD transmission have recently been published.¹⁰² Direct transmission of CWD between animals occurred, although the exact mechanism was not determined. The role of environmental contamination in maintaining infectivity is not entirely understood; however, controlled studies showed infectivity remained on pastures in which CWD-affected deer resided approximately 2 years previously. These studies were conducted in pastures presumed to be highly contaminated. Thus, extrapolation to field situations should be done with care, but these data suggest caution in managing pastures or paddocks that have housed CWD-affected cervids. In addition, mule deer were infected by contact with skeletal remains of CWD-affected deer and surrounding ground and vegetation. This information bolsters the need for caution when moving portions of harvested cervids that contain the highest amount of infectivity, such as the head and the spine, to areas where CWD does not exist.

	Regulatory Considerations

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
Concomitant with growing concerns about CWD has been an increase in guidelines and regulations governing farmed cervids and management of free-ranging deer and elk. Following recognition of CWD in farmed elk, states, provinces, and federal animal health regulatory agencies developed voluntary and/or mandatory programs to control or manage the disease, with the ultimate goal of eradication of CWD from these industries. Details of these programs are available online at the various state and provincial Web sites and from the Canadian Food Inspection Agency (http://www.inspection.gc.ca/english/anima/heasan/disemala/cwdmdc/certnorme.shtml) and the US Department of Agriculture (http://www.aphis/usda.gov/vs/nahps/cwd/farmed-cwd.html).

These programs are based on individual animal identification, annual census and visual inspection, and testing of animals dying on the farm, when harvested, or at slaughter, to establish certified herds after years (typically 5 years) of monitoring. If CWD is identified, herds are quarantined, they might be depopulated with indemnity, and herd and premises plans are developed. At the time of writing, only two elk herds (Colorado) and one white-tailed deer herd (Wisconsin) were under quarantine for CWD.

Management of CWD in free-ranging herds is more difficult than in farmed cervids and varies depending on jurisdiction and history of CWD in that location. For example, an ambitious program of white-tailed deer population reduction is being pursued in the relatively small CWD endemic area in Wisconsin (www.dnr.state.wi.us/org/land/wildlife/whealth/issues/cwd/index.htm). In the much larger geographic area in which CWD occurs in Wyoming, Colorado, and contiguous states, eradication is impossible with currently available techniques. Management of CWD in these areas varies among states and can include surveillance, attempts to prevent geographic spread, and efforts to reduce prevalence through population reduction. Most states or provinces provide guidance to hunters or have restrictions concerning transport from CWD endemic areas of tissues of highest infectivity from harvested deer and elk, particularly skull containing brain and vertebral column containing spinal cord. Most jurisdictions recommend transporting only deboned meat, cleaned skull cap and antlers, and hides. A list of state and provincial regulations related to CWD has been compiled and is available online (http://www.cwd-info.org/index.php/fuseaction/policy.regulations).

Concerns about safe handling of animals and tissues suspected of having CWD or scrapie led the American Association of Veterinary Laboratory Diagnosticians (AAVLD) to develop best management practices for handling animal TSE agents classified as biosafety level 2 agents, including CWD, scrapie, and TME. Details are available to members on the AAVLD Web site (http://www.aavld.org/aavld-3/Current_news.jsp)³ or to the public on the Wyoming State Veterinary Laboratory web site (http://wyovet.uwyo.edu/WSVL/updates/UPDATES_BY_YEAR/Updates_2004.htm) and should be consulted if working with these agents in diagnostic laboratories. The primary features of these guidelines are shown in Table 5.

	Summary

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 
CWD is a unique TSE and has inherent challenges beyond those of the domestic animal TSEs. Transmission readily occurs among cervids; no complete genetic resistance has been identified, and environmental contamination might be important in maintenance of the disease. Although CWD probably can be controlled in farmed cervid industries, management of CWD in free-ranging populations of deer and elk is problematic, and it is likely the disease will continue to spread. Veterinary pathologists need to be aware of the features of CWD and will be important participants in surveillance programs and investigation of CWD natural history and biology in the future.

	Acknowledgments

 
I gratefully acknowledge the mentorship of Dr. Stuart Young, and this review is dedicated to his memory. Through many exciting discussions and untold hours of working on the microscope, he was an inspiration. He will be missed. I also acknowledge a long-standing collaboration and innumerable discussions about CWD with Dr. Mike Miller with the Colorado Division of Wildlife and Dr. Tom Thorne with the Wyoming Game and Fish Department. Discussions with Dr. Jean Jewell about genetics and molecular biology have been particularly helpful. Collaboration and discussion with too many individuals working with the TSEs to mention individually are gratefully acknowledged. Partial support was provided by the Department of Veterinary Sciences, University of Wyoming; National Science Foundation–National Institutes of Health Grant DEB-0091961; Department of Defense Grant DAMD 17-03-1-0542; and the National Cattlemen's Beef Association.

	Footnotes

 
¹ Deceased December 29, 2004. This paper was in revision at the time of Dr. Williams's death. Final edits were completed by her collaborators, Dr. Jean Jewell at the University of Wyoming and Dr. Mike Miller of the Colorado Division of Wildlife.

An electronic copy of this review may be viewed at: http://wyovet.uwyo.edu in Updates on Diseases.

	References

Top Abstract Clinical and Epidemiologic... Gross Pathology Histopathology and Electron... Diagnostic Techniques Differential Diagnoses Pathogenesis Genetics Host Range Origin and Strain Typing Transmission Regulatory Considerations Summary References

 

1. Adcock JL, Keiss RE: Locoism in elk. Bull Wildl Dis Assoc 5:121-124, 1969
2. Agricultural Research Service: US Department of Agricultural Report of scrapie seminar. Rep Scrapie Sem p 378, 1964
3. American Association of Veterinary Laboratory Diagnosticians' Laboratory Safety and Waste Disposal Committee and Pathology Committee: Best management practices for handling suspect biosafety level 2 animal transmissible spongiform encephalopathy (TSE) diagnostic samples (scrapie, chronic wasting disease and transmissible mink encephalopathy) in animal health laboratories. American Association of Veterinary Laboratory Diagnosticians January 2005 http://www.aavld.org/aavld-3/current_news.jsp
4. Andreoletti O, Berthon P, Marc D, Sarradin P, Grosclaude J, van Keulen L, Schelcher F, Elsen JM, Lantier F: Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 81:3115-3126, 2000[Abstract/Free Full Text]
5. Andreoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, Lantier F, Berthon P, Eychenne F, Lafond-Benestad S, Elsen JM, Schelcher F: PrP(Sc) accumulation in placentas of ewes exposed to natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. J Gen Virol 83:2607-2616, 2002[Abstract/Free Full Text]
6. Andreoletti O, Simon S, Lacroux C, Morel N, Tabouret G, Chabert A, Lugan S, Corbiere F, Ferre P, Foucras G, Laude H, Eychenne F, Grassi J, Schelcher F: PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat Med 10:591-593, 2004[CrossRef][Web of Science][Medline]
7. Austin AR, Pawson L, Meek S, Webster S: Abnormalities of heart rate and rhythm in bovine spongiform encephalopathy. Vet Rec 141:352-357, 1997[Abstract/Free Full Text]
8. Bahmanyar S, Williams ES, Johnson FB, Young S, Gajdusek DC: Amyloid plaques in spongiform encephalopathy of mule deer. J Comp Pathol 95:1-5, 1985[CrossRef][Web of Science][Medline]
9. Balakirev ES, Ayala FJ: Pseudogenes: are they "junk" or functional DNA? Annu Rev Genet 37:123-151, 2003[CrossRef][Web of Science][Medline]
10. Ball K: Chronic wasting disease in a Rocky Mountain elk. Can Vet J 43:880-882, 2002[Web of Science][Medline]
11. Bartz JC, Marsh RF, McKenzie DI, Aiken JM: The host range of chronic wasting disease is altered on passage in ferrets. Virol 251:297-301, 1998
12. Bastian FO, Dash S, Garry RF: Linking chronic wasting disease to scrapie by comparison of Spiroplasma mirum ribosomal DNA sequences. Exp Mol Pathol 77:49-56, 2004[CrossRef][Web of Science][Medline]
13. Beck E, Daniel PM: Kuru and Creutzfeldt-Jakob disease; neuropathological lesions and their significance. In: Slow Transmissible Diseases of the Nervous System, ed. Prusiner SB and Hadlow WJ, pp 253-270, Academic Press, New York 1979
14. Beck E, Daniel PM, Parry HB: Degeneration of cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie; and its relationship to human system degenerations. Brain 87:153-176, 1964[Free Full Text]
15. Beekes M, Baldauf E, Diringer H: Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol 77:1925-1934, 1996[Abstract/Free Full Text]
16. Beekes M, McBride PA: Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci Lett 278:181-184, 2000[CrossRef][Web of Science][Medline]
17. Beekes M, McBride PA, Baldauf E: Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 79:601-607, 1998[Abstract]
18. Belay ED, Gambetti P, Schonberger LB, Parchi P, Lyon DR, Capellari S, McQuiston JH, Bradley K, Dowdle G, Crutcher JM, Nichols CR: Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol 58:1673-1678, 2001[Abstract/Free Full Text]
19. Belay ED, Maddox RA, Gambetti P, Schonberger LB: Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology 60:176-181, 2003[Abstract/Free Full Text]
20. Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB: Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 10:977-984, 2004[Web of Science][Medline]
21. Bosque PJ: Bovine spongiform encephalopathy, chronic wasting disease, scrapie, and the threat to humans from prion disease epizootics. Curr Neurol Neurosci Rep 2:488-495, 2002[Medline]
22. Bosque PJ, Ryou C, Telling G, Peretz D, Legname G, DeArmond SJ, Prusiner SB: Prions in skeletal muscle. Proc Natl Acad Sci USA 99:3812-3817, 2002[Abstract/Free Full Text]
23. Bossers A, de Vries R, Smits MA: Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants on PrP. J Virol 74:1407-1414, 2000[Abstract/Free Full Text]
24. Brayton KA, O'Rourke KI, Lyda AK, Miller MW, Knowles DP: A processed pseudogene contributes to apparent mule deer prion gene heterogeneity. Gene 326:167-173, 2004[CrossRef][Web of Science][Medline]
25. Brown P, Wolff A, Gajdusek DC: A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887-890, 1990[Abstract/Free Full Text]
26. Browning SR, Mason GL, Seward T, Green M, Eliason GA, Mathiason C, Miller MW, Williams ES, Hoover E, Telling GC: Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol 78:13345-13350, 2004[Abstract/Free Full Text]
27. Bruce M, Chree A, Williams ES, Fraser H: Perivascular PrP amyloid in the brains of mice infected with chronic wasting disease. Brain Pathol 10:662-663, 2000 [Abstract C632–608]
28. Bruce ME, Boyle A, Cousens S, McConnell I, Foster J, Goldmann W, Fraser H: Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol 83:695-704, 2002[Abstract/Free Full Text]
29. Bruce ME, Fraser H: Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurobiol 1:189-202, 1975[Web of Science]
30. Bruce ME, Fraser H, McBride PA, Scott JR, Dickinson AG: The basis of strain variation in scrapie. In: Prion Diseases of Humans and Animals, ed. Prusiner SB, Collinge J, Powell J, and Anderton B, pp 497-508, Ellis Horwood, London 1992
31. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmission to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498-501, 1997[CrossRef][Medline]
32. Centers for Disease Control and Prevention and National Institutes of Health: Biosafety in Microbiological and Biomedical Laboratories, 4th ed. US Department of Health and Human Services, US Government Printing Office, Washington, DC 1999
33. Cérvenakova L, Rohwer R, Williams ES, Brown P, Gajdusek DC: High sequence homology of the PrP gene in mule deer and Rocky Mountain elk. Lancet 350:219-220, 1997[Web of Science][Medline]
34. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685-690, 1996[CrossRef][Medline]
35. Conner MM, McCarty CW, Miller MW: Detection of bias in harvest-based estimates of chronic wasting disease prevalence in mule deer. J Wildl Dis 36:691-699, 2000[Abstract]
36. Cutlip RC, Miller JM, Hamir AN, Peters J, Robinson MM, Jenny AL, Lehmkuhl HD, Taylor WD, Bisplingh-off FD: Resistance of cattle to scrapie by the oral route. Can J Vet Res 65:131-132, 2001[Web of Science][Medline]
37. Cutlip RC, Miller JM, Lehmkuhl HD: Second passage of a US scrapie agent in cattle. J Comp Pathol 117:271-275, 1997[CrossRef][Web of Science][Medline]
38. Cutlip RC, Miller JM, Race RE, Jenny AL, Katz JB, Lehmkuhl HD, DeBey BM, Robinson MM: Intracerebral transmission of scrapie to cattle. J Infect Dis 169:814-820, 1994[Web of Science][Medline]
39. Dawson M, Hoinville LJ, Hosie BD, Hunter N: Guidance on the use of PrP genotyping as an aid to the control of clinical scrapie. Vet Rec 142:623-625, 1998[Web of Science][Medline]
40. Detwiler LA: Scrapie. Sci Tech Rev Off Int Epizootics 11:491-537, 1992
41. Ernst DR, Race RE: Comparative analysis of scrapie agent inactivation methods. J Virol Methods 41:193-201, 1993[CrossRef][Web of Science][Medline]
42. Fraser H: The pathology of natural and experimental scrapie. In: Slow Virus Diseases of Animals and Man, ed. Kimberlin RH, p 404, American Elsevier Publishing Company, Inc., New York, NY 1976
43. Fraser H, Dickinson AG: The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78:301-311, 1968[CrossRef][Web of Science][Medline]
44. Gajdusek DC: The potential risk to humans of amyloids in animals. In: Bovine Spongiform Encephalopathy. The BSE Dilemma, ed. Gibbs CJ Jr, pp 1-7, Springer-Verlag, New York, NY 1996
45. Glatzel M, Abela E, Maissen M, Aguzzi A: Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349:1812-1820, 2003[Abstract/Free Full Text]
46. Gonzalez L, Martin S, Begara-McGorum I, Hunter N, Houston F, Simmons M, Jeffrey M: Effect of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Pathol 126:17-29, 2002[CrossRef][Web of Science][Medline]
47. Gould DH, Voss JL, Miller MW, Bachand AM, Cummings BA, Frank AA: Survey of cattle in northeast Colorado for evidence of chronic wasting disease: geographical and high-risk targeted sample. J Vet Diagn Invest 15:274-277, 2003[Abstract/Free Full Text]
48. Gravenor MB, Stallard N, Curnow R, McLean AR: Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci USA 100:10960-10965, 2003[Abstract/Free Full Text]
49. Guiroy DC, Liberski PP, Williams ES, Gajdusek DC: Electron microscopic findings in brain of Rocky Mountain elk with chronic wasting disease. Folia Neuropathol 32:171-173, 1994[Medline]
50. Guiroy DC, Williams ES, Liberski PP, Wakayama I, Gajdusek DC: Ultrastructural neuropathology of chronic wasting disease in captive mule deer. Acta Neuropathol (Berl) 85:437-444, 1993[CrossRef][Medline]
51. Guiroy DC, Williams ES, Yanagihara R, Gajdusek DC: Immunolocalization of scrapie amyloid (PrP27-30) in chronic wasting disease of Rocky Mountain elk and hybrids of captive mule deer and white-tailed deer. Neurosci Lett 126:195-198, 1991[CrossRef][Web of Science][Medline]
52. Guiroy DC, Williams ES, Yanagihara R, Gajdusek DC: Topographic distribution of scrapie amyloid-immuno-reactive plaques in chronic wasting disease in captive mule deer (Odocoileus hemionus hemionus). Acta Neuropathol (Berl) 81:475-478, 1991[CrossRef][Medline]
53. Hadlow WJ: Differing neurohistologic images of scrapie, transmissible mink encephalopathy, and chronic wasting disease of mule deer and elk. In: Bovine Spongiform Encephalopathy. The BSE Dilemma, ed. Gibbs CJ Jr, pp 122-137, Springer-Verlag, New York, NY 1996
54. Hadlow WJ: Reflections on the transmissible spongiform encephalopathies. Vet Pathol 36:523-529, 1999[CrossRef][Web of Science][Medline]
55. Hadlow WJ, Kennedy RC, Race RE: Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 146:657-664, 1982[Web of Science][Medline]
56. Hainfellner JA, Liberski PP, Guiroy DC, Brown P, Cervenakova L, Gajdusek DC, Budka H: Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7:547-553, 1997[Web of Science][Medline]
57. Hamir AN, Cutlip R, Stack M, Chaplin MC, Bartz J, Jenny A, Williams ES: Experimental inoculation of TME, scrapie, and CWD to raccoons and the utilization of raccoons for strain-typing of unknown TSEs in the USA. Int Conf Transmissible Spongiform Encephalopathies P1.1:17 2002
58. Hamir AN, Cutlip RC, Miller JM, Williams ES, Stack MJ, Miller MW, O'Rourke KI, Chaplin MJ: Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J Vet Diagn Invest 13:91-96, 2001[Abstract/Free Full Text]
59. Hamir AN, Kunkle RA, Cutlip RC, Miller JM, O'Rourke KI, Williams ES, Miller MW, Stack MJ, Chaplin MJ, Richt JA: Experimental transmission of chronic wasting disease agent to cattle by intracerebral route. J Vet Diagn Invest (in press)
60. Hamir AN, Miller JL, Cutlip RC: Failure to detect prion protein (PrPres) by immunohistochemistry in striated muscle tissues of animals experimentally inoculated with agents of transmissible spongiform encephalopathy. Vet Pathol 41:78-81, 2004[Abstract/Free Full Text]
61. Hamir AN, Miller JM, Cutlip RC, Kunkle RA, Jenny AL, Stack MJ, Chaplin MJ, Richt JA: Transmission of sheep scrapie to elk (Cervus elaphus nelsoni) by intracerebral inoculation: final outcome of the experiment. J Vet Diagn Invest 16:316-321, 2004[Abstract/Free Full Text]
62. Hamir AN, Miller JM, Cutlip RC, Stack MJ, Chaplin MJ, Jenny AL: Preliminary observations on the experimental transmission of scrapie to elk (Cervus elaphus nelsoni) by intracerebral inoculation. Vet Pathol 40:81-85, 2003[Abstract/Free Full Text]
63. Hamir AN, Miller JM, Cutlip RC, Stack MJ, Chaplin MJ, Jenny AL, Williams ES: Experimental inoculation of scrapie and chronic wasting disease agents in raccoons (Procyon lotor). Vet Rec 153:121-123, 2003[Free Full Text]
64. Hamir AN, Miller JM, O'Rourke KI, Bartz JC, Stack MJ, Chaplin MJ: Transmission of transmissible mink encephalopathy to raccoons (Procyon lotor) by intracerebral inoculation. J Vet Diagn Invest 16:57-63, 2004[Abstract/Free Full Text]
65. Haritani M, Spencer YI, Wells GAH: Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin fixed bovine spongiform encephalopathy affected brain. Acta Neuropathol 87:86-90, 1994[Medline]
66. Heaton MP, Leymaster KA, Freking BA, Hawk DA, Smith TP, Keele JW, Snelling WM, Fox JM, Chitko-McKown CG, Laegreid WW: Prion gene sequence variation within diverse groups of U.S. sheep, beef cattle, and deer. Mamm Genome 14:765-777, 2003[CrossRef][Web of Science][Medline]
67. Heggebo R, Gonzalez L, Press CM, Gunnes G, Espenes A, Jeffrey M: Disease-associated PrP in the enteric nervous system of scrapie-affected Suffolk sheep. J Gen Virol 84:1327-1338, 2003[Abstract/Free Full Text]
68. Heggebo R, Press CM, Gunnes G, Gonzalez L, Jeffrey M: Distribution and accumulation of PrP in gut-associated and peripheral lymphoid tissue of scrapie-affected Suffolk sheep. J Gen Virol 83:479-489, 2002[Abstract/Free Full Text]
69. Heggebo R, Press CM, Gunnes G, Lie KI, Tranulis MA, Ulvund M, Groschup MH, Landsverk T: Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent. J Gen Virol 81:2327-2337, 2000[Abstract/Free Full Text]
70. Heggebo R, Press CM, Gunnes G, Ulvund MJ, Tranulis MA, Lsverk T: Detection of PrPSc in lymphoid tissues of lambs experimentally exposed to the scrapie agent. J Comp Pathol 128:172-181, 2003[CrossRef][Web of Science][Medline]
71. Hibler CP, Wilson KL, Spraker TR, Miller MW, Zink RR, DeBuse LL, Andersen E, Schweitzer D, Kennedy JA, Baeten LA, Smeltzer JF, Salman MD, Powers BE: Field validation and assessment of an enzyme-linked immunosorbent assay for detecting chronic wasting disease in mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni). J Vet Diagn Invest 15:311-319, 2003[Abstract/Free Full Text]
72. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P: The same prion strain causes vCJD and BSE. Nature 389:448-450, 1997[CrossRef][Medline]
73. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ: Transmission of BSE by blood transmission in sheep. Lancet 356:999-1000, 2000[CrossRef][Web of Science][Medline]
74. Howerth EW, Stallknecht DE, Kirkland PD: Blue-tongue, epizootic hemorrhagic disease, and other orbi-virus-related diseases. In: Infectious Diseases of Wild Mammals, ed. Williams ES and Barker IK, 3rd ed., pp 77-97, Iowa State University Press, Ames, IA 2001
75. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F: Transmission of prion diseases by blood transfusion. J Gen Virol 83:2897-2905, 2002[Abstract/Free Full Text]
76. Hunter N, Foster JD, Dickinson AG, Hope J: Linkage of the gene for the scrapie-associated fibril protein (PrP) to the Sip gene in cheviot sheep. Vet Rec 124:364-366, 1989[Abstract]
77. Hunter N, Foster JD, Hope J: Natural scrapie in British sheep: breeds, ages and PrP gene polymorphisms. Vet Rec 130:389-392, 1992[Abstract]
78. Hunter N, Goldmann W, Marshall E, O'Neill G: Sheep and goats: natural and experimental TSEs and factors influencing incidence of disease. Arch Virol 16:181-188, 2000
79. Hunter N, Goldmann W, Smith G, Hope J: The association of a codon 136 PrP gene variant with the occurrence of natural scrapie. Arch Virol 137:171-177, 1994[CrossRef][Web of Science][Medline]
80. Hunter N, Moore L, Hosie BD, Dingwall WS, Greig A: Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland. Vet Rec 140:59-63, 1997[Abstract/Free Full Text]
81. Ironside JW, Head MW: Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. In: Mad Cow Disease and Related Spongiform Encephalopathies, ed. Harris DA, pp 133-159, Springer-Verlag, New York, NY 2004
82. Jeffrey M, Gonzalez L: Pathology and pathogenesis and bovine spongiform encephalopathy and scrapie. In: Mad Cow Disease and Related Spongiform Encephalopathies, ed. Harris DA, pp 65-97, Springer-Verlag, New York, NY 2004
83. Jeffrey M, Martin S, Gonzalez L: Cell-associated variants of disease-specific prion protein immunolabelling are found in different sources of sheep transmissible spongiform encephalopathy. J Gen Virol 84:1033-1045, 2003[Abstract/Free Full Text]
84. Jewell JE, Conner MM, Wolfe LL, Miller MW, Williams ES: Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease. J Gen Virol 86:2127-2134, 2005[Abstract/Free Full Text]
85. Jewell JE, Pahl J, Williams ES: An apparent duplication of the prion protein coding sequence in mule deer (Odocoileus hemionus). 52nd Annu Conf Wildl Dis Assoc 90:121-122, 2003
86. Johnson C, Johnson J, Clayton M, McKenzie D, Aiken J: Prion protein gene heterogeneity in free-ranging white-tailed deer within the chronic wasting disease affected region of Wisconsin. J Wildl Dis 39:576-581, 2003[Abstract]
87. Kahn S, Dube C, Bates L, Balachandran A: Chronic wasting disease in Canada: part 1. Can Vet J 45:397-404, 2004[Web of Science][Medline]
88. Kimberlin R, Walker C: Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol 88:39-47, 1978[CrossRef][Web of Science][Medline]
89. Kimberlin RH, Walker CA: Pathogenesis of scrapie in mice after intragastric infection. Virus Res 12:213-220, 1989[CrossRef][Web of Science][Medline]
90. Krumm CE, Conner MM, Miller MW: Susceptibility of chronic-wasting disease (CWD)–infected deer to vehicle collision. Proceedings, Joint Meeting of the American Association of Zoo Medicine, Wildlife Disease Association, and American Association of Wildlife Veterinarians, 151 2004
91. Lankester MW: Extrapulmonary lungworms of cervids. In: Parasitic Diseases of Wild Mammals, ed. Samuel MD, Pybus MJ, and Kocan AA, 2nd ed., pp 228-278, Iowa State University Press, Ames, IA 2001
92. Larsen CT, Wolff A, Williams ES, Miller MW: Investigation of chronic wasting disease strain variation using ferrets (Mustela putorius furo). Proceedings, Joint Conference of the American Association of Zoo Veterinarians, The Wildlife Disease Association, and the American Association of Wildlife Veterinarians, 226 2004
93. Lasmezas CI, Deslys J-P, Demalmay R, Adjou KT, Lamoury F, Dormont D, Robain O, Ironside J, Hauw J-J: BSE transmission to macaques. Nature 381:743-744, 1996[CrossRef][Medline]
94. Liberski PP, Guiroy DC, Williams ES, Walis A, Budka H: Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease. Acta Neuropathol (Berl) 102:496-500, 2001[Medline]
95. Liberski PP, Guiroy DC, Williams ES, Yangihara R, Brown P, Gajdusek DC: The amyloid plaque. In: Light and Microscopic Neuropathology of Slow Virus Disorders, ed. Liberski PP, pp 295-347, CRC Press, Boca Raton, FL 1993
96. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417-421, 2004[CrossRef][Web of Science][Medline]
97. Miller JM, Jenny AL, Taylor WD, Marsh RF, Rubenstein R, Race RE: Immunohistochemical detection of prion protein in sheep with scrapie. J Vet Diagn Invest 5:309-316, 1993[Abstract/Free Full Text]
98. Miller MW, Williams ES: Detection of PrP(CWD) in mule deer by immunohistochemistry of lymphoid tissues. Vet Rec 151:610-612, 2002[Free Full Text]
99. Miller MW, Williams ES: Prion disease: horizontal prion transmission in mule deer. Nature 425:35-36, 2003[CrossRef][Medline]
100. Miller MW, Williams ES: Chronic wasting disease of cervids. In: Mad Cow Disease and Related Spongiform Encephalopathies, ed. Harris DA, pp 193-214, Springer-Verlag, New York, NY 2004
101. Miller MW, Williams ES, Hobbs NT, Wolfe LL: Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10:1003-1006, 2004[Web of Science][Medline]
102. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ, Larsen CT, Thorne ET: Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming. J Wildl Dis 36:676-690, 2000[Abstract]
103. Mulcahy ER, Bartz JC, Kincaid AE, Bessen RA: Prion infection of skeletal muscle cells and papillae in the tongue. J Virol 78:6792-6798, 2004[Abstract/Free Full Text]
104. New York State Department of Agriculture and Markets: DEC announces sampling results for chronic wasting disease. June 2005. http://www.agmkt.state.ny.us/AD/release.asp?ReleaseID=1438
105. O'Rourke KI, Baszler TV, Besser TE, Miller JM, Cutlip RC, Wells GA, Ryder SJ, Parish SM, Hamir AN, Cockett NE, Jenny A, Knowles DP: Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 38:3254-3259, 2000[Abstract/Free Full Text]
106. O'Rourke KI, Baszler TV, Miller JM, Spraker TR, Sadler-Riggleman I, Knowles DP: Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein. Vet Rec 36:1750-1755, 1998
107. O'Rourke KI, Baszler TV, Parish SM, Knowles DP: Preclinical detection of PrPSc in nictitating membrane lymphoid tissue of sheep. Vet Rec 142:489-491, 1998[Free Full Text]
108. O'Rourke KI, Besser TE, Miller MW, Cline TF, Spraker TR, Jenny AL, Wild MA, Zebarth GL, Williams ES: PrP genotypes of captive and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease. J Gen Virol 80:2765-2769, 1999[Abstract/Free Full Text]
109. O'Rourke KI, Duncan JV, Logan JR, Anderson AK, Norden DK, Williams ES, Combs BA, Stobart RH, Moss GE, Sutton DL: Active surveillance for scrapie by third eyelid biopsy and genetic susceptibility testing of flocks of sheep in Wyoming. Clin Diagn Lab Immunol 9:966-971, 2002[Abstract/Free Full Text]
110. O'Rourke KI, Holyoak GR, Clark WW, Mickelson JR, Wang S, Melco RP, Besser TE, Foote WC: PrP genotypes and experimental scrapie in orally inoculated Suffolk sheep in the United States. J Gen Virol 78:975-978, 1997[Abstract]
111. O'Rourke KI, Spraker TR, Hamburg LK, Besser TE, Brayton KA, Knowles DP: Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting disease in white-tailed deer. J Gen Virol 85:1339-1346, 2004[Abstract/Free Full Text]
112. O'Rourke KI, Zhuang D, Lyda A, Gomez G, Williams ES, Tuo W, Miller MW: Abundant PrP(CWD) in tonsil from mule deer with preclinical chronic wasting disease. J Vet Diagn Invest 15:320-323, 2003[Abstract/Free Full Text]
113. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H: Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Annals Neurol 46:224-233, 1999[CrossRef][Web of Science][Medline]
114. Parry HB: Scrapie: a transmissible hereditary disease of sheep. Nature 185:441-443, 1960[Medline]
115. Parry HB: Scrapie disease of sheep: historical, clinical, epidemiological and practical aspects of the natural disease. p 192, Academic Press, New York, NY 1983
116. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW: Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529, 2004[CrossRef][Web of Science][Medline]
117. Peters J, Miller JM, Jenny AL, Peterson TL, Carmichael KP: Immunohistochemical diagnosis of chronic wasting disease in preclinically affected elk from a captive herd. J Vet Diagn Invest 12:579-582, 2000[Abstract/Free Full Text]
118. Priola SA, Vorberg I: Identification of possible animal origins of prion disease in human beings. Lancet 363:2013-2014, 2004[CrossRef][Web of Science][Medline]
119. Prusiner S: Scrapie prions. Annu Rev Microbiol 43:345-374, 1989[CrossRef][Web of Science][Medline]
120. Prusiner S: An introduction to prion biology and diseases. In: Prion Biology and Diseases, ed. Prusiner S, 2nd ed., pp 1-87, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 2004
121. Prusiner S, Cochran SP, Groth DF, Downey DE, Bowerman KA, Martinez HM: Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353-358, 1982[CrossRef][Web of Science][Medline]
122. Race R, Jenny A, Sutton D: Scrapie infectivity and proteinase K–resistant prion protein in sheep placenta, brain, spleen, and lymph node: implications for transmission and antemortem diagnosis. J Infect Dis 178:949-953, 1998[Web of Science][Medline]
123. Race RE, Raines A, Baron TGM, Miller MW, Jenny A, Williams ES: Comparison of abnormal prion protein glycoform patterns from transmissible spongiform encephalopathy agent-infected deer, elk, sheep, and cattle. J Virol 76:12365-12368, 2002[Abstract/Free Full Text]
124. Race RE, Raymond GJ: Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol 78:2164-2165, 2004[Abstract/Free Full Text]
125. Raymond GJ, Bossers A, Raymond LD, O'Rourke KI, McHolland LE, Bryant PK, 3rd Miller MW, Williams ES, Smits M, Caughey B: Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 19:4425-4430, 2000[CrossRef][Web of Science][Medline]
126. Robinson MM, Hadlow WJ, Knowles DP, Huff TP, Lacy PA, Marsh RF, Gorham JR: Infection of cattle with the agents of TME and scrapie. J Comp Pathol 113:241-251, 1995[CrossRef][Web of Science][Medline]
127. Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, Ball H, Legname G, Leclerc E, Solforosi L, Serban H, Groth D, Burton DR, Prusiner SB, Williamson RA: Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20:1147-1150, 2002[CrossRef][Web of Science][Medline]
128. Schatzl HM, Wopfner F, Gilch S, von Brunn A, Jager G: Is codon 129 of prion protein polymorphic in human beings but not in animal? Lancet 349:219-220, 1997[CrossRef][Web of Science][Medline]
129. Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA: Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 142:564-568, 1998[Abstract/Free Full Text]
130. Sigurdson CJ, Barillas-Mury C, Miller MW, Oesch B, Van Keulen LJM, Langeveld JPM, Hoover EA: Pr-PCWD lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J Gen Virol 83:2617-2628, 2002[Abstract/Free Full Text]
131. Sigurdson CJ, Spraker TR, Miller MW, Oesch B, Hoover EA: PrP(CWD) in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J Gen Virol 82:2327-2334, 2001[Abstract/Free Full Text]
132. Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O'Rourke KI, Hoover EA: Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 80:2757-2764, 1999[Abstract/Free Full Text]
133. Sohn H-J, Kim J-H, Choi K-S, Nah J-J, Joo Y-S, Jean Y-H, Ahn S-W, Kim O-K, Kim D-Y, Balachandran A: A case of chronic wasting disease in an elk imported to Korea from Canada. J Vet Med Sci 64:855-858, 2002[CrossRef][Web of Science][Medline]
134. Spraker TR, Balachandran A, Zhuang D, O'Rourke KI: Variable patterns of distribution of PrP(CWD) in the obex and cranial lymphoid tissues of Rocky Mountain elk (Cervus elaphus nelsoni) with subclinical chronic wasting disease. Vet Rec 155:295-302, 2004[Abstract/Free Full Text]
135. Spraker TR, Miller MW, Williams ES, Getzy DM, Adrian WJ, Schoonveld GG, Spowart RA, O'Rourke KI, Miller JM, Merz PA: Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado. J Wildl Dis 33:1-6, 1997[Abstract]
136. Spraker TR, O'Rourke KI, Balachandran A, Zink RN, Cummings BA, Miller MW, Powers BE: Validation of monoclonal antibody F99/97.6.1 for immunohistochemistry staining of brain and tonsil in mule deer (Odocoileus hemionus) with chronic wasting disease. J Vet Diagn Invest 14:3-7, 2002[Abstract/Free Full Text]
137. Spraker TR, Zink RR, Cummings BA, Sigurdson CJ, Miller MW, O'Rourke KI: Distribution of protease-resistant prion protein and spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease. Vet Pathol 39:546-556, 2002[Abstract/Free Full Text]
138. Spraker TR, Zink RR, Cummings BA, Wild MA, Miller MW, O'Rourke KI: Comparison of histological lesions and immunohistochemical staining of proteinase-resistant prion protein in a naturally occurring spongiform encephalopathy of free-ranging mule deer (Odocoileus hemionus) with those of chronic wasting disease of captive mule deer. Vet Pathol 39:110-119, 2002[Abstract/Free Full Text]
139. Taylor DM: Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159:10-17, 2000[CrossRef][Web of Science][Medline]
140. Taylor DM, Brown JM, Fernie K, McConnell I: The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 58:167-174, 1997[CrossRef][Web of Science][Medline]
141. Thomzig A, Kratzel C, Lenz G, Kruger D, Beekes M: Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 4:530-533, 2003[CrossRef][Web of Science][Medline]
142. Thomzig A, Schulz-Schaeffer W, Kratzel C, Mai J, Beekes M: Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie. J Clin Invest 113:1465-1472, 2004[CrossRef][Web of Science][Medline]
143. Tuo W, O'Rourke KI, Zhuang D, Cheevers WP, Spraker TR, Knowles DP: Pregnancy status and fetal prion genetics determine PrPSc accumulation in placentomes of scrapie-infected sheep. Proc Natl Acad Sci USA 99:6310-6315, 2002[Abstract/Free Full Text]
144. Tuo W, Zhuang D, Knowles DP, Cheevers WP, Sy MS, O'Rourke KI: Prp-c and Prp-Sc at the fetal-maternal interface. J Biol Chem 276:18229-18234, 2001[Abstract/Free Full Text]
145. US Department of Agriculture Animal Plant Health Inspection Service: Position paper on official diagnosis of chronic wasting disease. US Department of Agriculture, February 2004. www.aphis.usda.gov/pa/issues/cwd/cwdposition.html
146. van Keulen LJ, Schreuder BE, Meloen RH, Mooij-Harkes G, Vromans ME, Langeveld JP: Immunohisto-chemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol 34:1228-1231, 1996[Abstract]
147. van Keulen LJ, Schreuder BE, Meloen RH, Poelen-van den Berg M, Mooij-Harkes G, Vromans ME, Langeveld JP: Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie. Vet Pathol 32:299-308, 1995[Abstract]
148. van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA: Scrapie-associated prion protein in the gastrointestinal tract of sheep with natural scrapie. J Comp Pathol 121:55-63, 1999[CrossRef][Web of Science][Medline]
149. van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA: Pathogenesis of natural scrapie in sheep. Arch Virol Suppl 16:57-71, 2000
150. Wild MA, Spraker TR, Sigurdson CJ, O'Rourke KI, Miller MW: Preclinical diagnosis of chronic wasting disease in captive mule deer (Odocoileus hemionus) and white-tailed deer (Odocoileus virginianus) using tonsillar biopsy. J Gen Virol 83:2629-2634, 2002[Abstract/Free Full Text]
151. Wilesmith JW, Hoinville LJ, Ryan JB, Sayers AR: Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986–1990. Vet Rec 130:197-201, 1992[Abstract]
152. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925, 1996[CrossRef][Web of Science][Medline]
153. Williams ES: Scrapie and chronic wasting disease. Clin Lab Med 23:139-159, 2003[CrossRef][Web of Science][Medline]
154. Williams ES, Kirkwood JK, Miller MW: Transmissible spongiform encephalopathies. In: Infectious Diseases of Wild Mammals, ed. Williams ES and Barker IK, 3rd ed., pp 292-301, Iowa State University Press, Ames, IA 2001
155. Williams ES, Miller MW: Chronic wasting disease in North American deer and elk. Rev Sci Tech 21:305-316, 2002[Web of Science][Medline]
156. Williams ES, Miller MW, Kreeger TJ, Kahn RH, Thorne ET: Chronic wasting disease of deer and elk: a review with recommendations for management. J Wildl Manag 66:551-563, 2002
157. Williams ES, Young S: Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 16:89-98, 1980[Abstract]
158. Williams ES, Young S: Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis 18:465-471, 1982[Abstract]
159. Williams ES, Young S: Spongiform encephalopathies of Cervidae. Rev Sci Tech Off Int Epizool 11:551-567, 1992
160. Williams ES, Young S: Neuropathology of chronic wasting disease of mule deer (Odocoileus hemionus) and elk (Cervus elaphus nelsoni). Vet Pathol 30:36-45, 1993[Abstract]
161. Williams ES, Young S, Marsh RF: Preliminary evidence of transmissibility of chronic wasting disease of mule deer. Proc Annu Meeting Wildl Dis Assoc 1985
162. Wolfe GJ, Lance WR: Locoweed poisoning in a northern New Mexico elk herd. J Range Manag 37:59-63, 1984
163. Wolfe LL, Conner MM, Baker TH, Dreitz VJ, Burnham KP, Williams ES, Hobbs NT, Miller MW: Evaluation of antemortem sampling to estimate chronic wasting disease prevalence in free-ranging mule deer. J Wildl Manag 66:564-573, 2002
164. Wolfe LL, Miller MW, Williams ES: Feasibility of "test and cull" as a strategy for managing chronic wasting disease in urban mule deer populations. Wildl Soc Bull 32:500-505, 2004[CrossRef]
165. Wood JLN, Done SH: Natural scrapie in goats: neuropathology. Vet Rec 131:93-96, 1992[Abstract]
166. World Health Organization: Infection control guidelines for transmissible spongiform encephalopathies. Report of a World Health Organization consultation. World Health Organization, Geneva, Switzerland 2000
167. World Health Organization: WHO consultation on public health and animal transmissible spongiform encephalopathies: epidemiology, risk and research requirements. p 52, World Health Organization, Geneva, Switzerland 2000

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

				G. Tamguney, M. W. Miller, K. Giles, A. Lemus, D. V. Glidden, S. J. DeArmond, and S. B. Prusiner Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein J. Gen. Virol., April 1, 2009; 90(4): 1035 - 1047. [Abstract] [Full Text] [PDF]

				A. N. Hamir, M. V. Palmer, and R. A. Kunkle Wasting and Neurologic Signs in a White-tailed Deer (Odocoileus virginianus) not Associated with Abnormal Prion Protein J. Wildl. Dis., October 1, 2008; 44(4): 1045 - 1050. [Abstract] [Full Text] [PDF]

				M. Perucchini, K. Griffin, M. W. Miller, and W. Goldmann PrP genotypes of free-ranging wapiti (Cervus elaphus nelsoni) with chronic wasting disease J. Gen. Virol., May 1, 2008; 89(5): 1324 - 1328. [Abstract] [Full Text] [PDF]

				A. N. Hamir, J. A. Richt, J. M. Miller, R. A. Kunkle, S. M. Hall, E. M. Nicholson, K. I. O'Rourke, J. J. Greenlee, and E. S. Williams Experimental Transmission of Chronic Wasting Disease (CWD) of Elk (Cervus elaphus nelsoni), White-tailed Deer (Odocoileus virginianus), and Mule Deer (Odocoileus hemionus hemionus) to White-tailed Deer by Intracerebral Route Vet. Pathol., May 1, 2008; 45(3): 297 - 306. [Abstract] [Full Text] [PDF]

				R. D. Harrington, T. V. Baszler, K. I. O'Rourke, D. A. Schneider, T. R. Spraker, H. D. Liggitt, and D. P. Knowles A species barrier limits transmission of chronic wasting disease to mink (Mustela vison) J. Gen. Virol., April 1, 2008; 89(4): 1086 - 1096. [Abstract] [Full Text] [PDF]

				K. M. Green, S. R. Browning, T. S. Seward, J. E. Jewell, D. L. Ross, M. A. Green, E. S. Williams, E. A. Hoover, and G. C. Telling The elk PRNP codon 132 polymorphism controls cervid and scrapie prion propagation J. Gen. Virol., February 1, 2008; 89(2): 598 - 608. [Abstract] [Full Text] [PDF]

				D. M. Green, V. J. del Rio Vilas, C. P. D. Birch, J. Johnson, I. Z. Kiss, N. D. McCarthy, and R. R. Kao Demographic risk factors for classical and atypical scrapie in Great Britain J. Gen. Virol., December 1, 2007; 88(12): 3486 - 3492. [Abstract] [Full Text] [PDF]

				C. M. Seabury, C. A. Gill, J. W. Templeton, J. B. Dyar, J. N. Derr, D. L. Adelson, E. Owens, D. S. Davis, D. C. Kraemer, and J. E. Womack Molecular Characterization of the Rocky Mountain Elk (Cervus elaphus nelsoni) PRNP Putative Promoter J. Hered., November 21, 2007; (2007) esm091v1. [Abstract] [Full Text] [PDF]

				A. N. Hamir, R. A. Kunkle, J. M. Miller, R. C. Cutlip, J. A. Richt, M. E. Kehrli Jr, and E. S. Williams Age-related lesions in laboratory-confined raccoons (Procyon lotor) inoculated with the agent of chronic wasting disease of mule deer J Vet Diagn Invest, November 1, 2007; 19(6): 680 - 686. [Abstract] [Full Text] [PDF]

				Y. Murayama, M. Yoshioka, H. Okada, M. Takata, T. Yokoyama, and S. Mohri Urinary excretion and blood level of prions in scrapie-infected hamsters J. Gen. Virol., October 1, 2007; 88(10): 2890 - 2898. [Abstract] [Full Text] [PDF]

				L. L. Wolfe, T. R. Spraker, L. Gonzalez, M. P. Dagleish, T. M. Sirochman, J. C. Brown, M. Jeffrey, and M. W. Miller PrPCWD in rectal lymphoid tissue of deer (Odocoileus spp.) J. Gen. Virol., July 1, 2007; 88(7): 2078 - 2082. [Abstract] [Full Text] [PDF]

				A. N. Hamir, J. M. Miller, R. A. Kunkle, S. M. Hall, and J. A. Richt Susceptibility of Cattle to First-passage Intracerebral Inoculation with Chronic Wasting Disease Agent from White-tailed Deer Vet. Pathol., July 1, 2007; 44(4): 487 - 493. [Abstract] [Full Text] [PDF]

				K. Meade-White, B. Race, M. Trifilo, A. Bossers, C. Favara, R. Lacasse, M. Miller, E. Williams, M. Oldstone, R. Race, et al. Resistance to Chronic Wasting Disease in Transgenic Mice Expressing a Naturally Occurring Allelic Variant of Deer Prion Protein J. Virol., May 1, 2007; 81(9): 4533 - 4539. [Abstract] [Full Text] [PDF]

				L. A. Baeten, B. E. Powers, J. E. Jewell, T. R. Spraker, and M. W. Miller A Natural Case of Chronic Wasting Disease in a Free-ranging Moose (Alces alces shirasi) J. Wildl. Dis., April 1, 2007; 43(2): 309 - 314. [Abstract] [Full Text] [PDF]

				C. J. Sigurdson, G. Manco, P. Schwarz, P. Liberski, E. A. Hoover, S. Hornemann, M. Polymenidou, M. W. Miller, M. Glatzel, and A. Aguzzi Strain Fidelity of Chronic Wasting Disease upon Murine Adaptation J. Virol., December 15, 2006; 80(24): 12303 - 12311. [Abstract] [Full Text] [PDF]

				G. LaFauci, R. I. Carp, H. C. Meeker, X. Ye, J. I. Kim, M. Natelli, M. Cedeno, R. B. Petersen, R. Kascsak, and R. Rubenstein Passage of chronic wasting disease prion into transgenic mice expressing Rocky Mountain elk (Cervus elaphus nelsoni) PrPC J. Gen. Virol., December 1, 2006; 87(12): 3773 - 3780. [Abstract] [Full Text] [PDF]

				A. N. Hamir, R. A. Kunkle, R. C. Cutlip, J. M. Miller, E. S. Williams, and J. A. Richt Transmission of chronic wasting disease of mule deer to Suffolk sheep following intracerebral inoculation J Vet Diagn Invest, November 1, 2006; 18(6): 558 - 565. [Abstract] [Full Text] [PDF]

				J. E. Jewell, J. Brown, T. Kreeger, and E. S. Williams Prion protein in cardiac muscle of elk (Cervus elaphus nelsoni) and white-tailed deer (Odocoileus virginianus) infected with chronic wasting disease. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3443 - 3450. [Abstract] [Full Text] [PDF]

				G. Tamguney, K. Giles, E. Bouzamondo-Bernstein, P. J. Bosque, M. W. Miller, J. Safar, S. J. DeArmond, and S. B. Prusiner Transmission of elk and deer prions to transgenic mice. J. Virol., September 1, 2006; 80(18): 9104 - 9114. [Abstract] [Full Text] [PDF]

				A. N. Hamir, R. A. Kunkle, J. M. Miller, and S. M. Hall Abnormal Prion Protein in Ectopic Lymphoid Tissue in a Kidney of an Asymptomatic White-tailed Deer Experimentally Inoculated with the Agent of Chronic Wasting Disease Vet. Pathol., May 1, 2006; 43(3): 367 - 369. [Abstract] [Full Text] [PDF]

				L. J. Lowenstine and R. J. Montali Historical Perspective and Future Directions in Training of Veterinary Pathologists with an Emphasis on Zoo and Wildlife Species J Vet Med Educ, January 1, 2006; 33(3): 338 - 345. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (54) Citing Articles via Google Scholar Google Scholar Articles by Williams, E. S. Search for Related Content PubMed PubMed Citation Articles by Williams, E. S. Social Bookmarking                            What's this?